Proteome Sciences plc (PRM) Receives Corporate Rating from FinnCap

Proteome Sciences plc (PRM) Receives Corporate Rating from FinnCap

Shares of Proteome Sciences plc (LON:PRM) traded down 1.7803% during mid-day trading on Tuesday, reaching GBX 4.7391. The company’s stock had a trading volume of 190,495 shares. Proteome Sciences plc has a 1-year low of GBX 3.50 and a 1-year high of GBX 20.25. The company’s 50 day moving average price is GBX 4.89 and its 200-day moving average price is GBX 4.98. The company’s market capitalization is GBX 11.61 million.

FinnCap reissued their corporate rating on shares of Proteome Sciences plc (LON:PRM) in a report released on Tuesday. FinnCap currently has a GBX 12 ($0.15) price target on the stock.

In other Proteome Sciences plc news, insider Martin Diggle bought 100,000 shares of the business’s stock in a transaction dated Tuesday, May 2nd. The stock was acquired at an average cost of GBX 5 ($0.06) per share, with a total value of £5,000 ($6,422.61). Over the last three months, insiders have bought 498,671 shares of company stock valued at $2,493,355.

Proteome Sciences plc Company Profile

Proteome Sciences plc is a protein biomarker company specializing in proteomics and peptidomics services and applications, and mass spectrometry (MS) protein analysis. The Company is engaged in biomarker research and development in applied proteomics and workflows using its techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “LSE:PRM”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Related posts

Leave a Comment